Finished product reference
Nandrolone Decanoate
Injection · Parenteral · 25 mg/1mL
- List code
- 884
- Pharmacologic class
- Anabolic steroid (androgen derivative)
What it is and how it works
Nandrolone decanoate is a long-acting ester of 19-nortestosterone that binds androgen receptors, with relatively greater anabolic than androgenic activity; it promotes protein synthesis, nitrogen retention and erythropoiesis.
Indications
Anaemia of chronic renal failure and certain aplastic anaemias; adjunct in postmenopausal osteoporosis and catabolic states in some markets.
Dosage and administration (summary)
Deep intramuscular injection, typically every 1–4 weeks, with dose and interval depending on the indication and response; specialist supervision is required.
Contraindications
Known or suspected prostate or male breast carcinoma, pregnancy, and hypercalcaemia or nephrotic syndrome in some labels.
Warnings and precautions
Virilisation in women (voice deepening, hirsutism, clitoromegaly) may be irreversible. Adverse effects on lipids, fluid retention, hepatic dysfunction and suppression of spermatogenesis may occur; monitor in cardiac, renal or hepatic disease and in children (premature epiphyseal closure). Misuse for performance enhancement carries serious health risks.
Pregnancy
Contraindicated because of the risk of virilisation of the female fetus.
Storage and supply
Store below 25 °C, protected from light.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.